EUVIMEDEUVIMED entdecken
Crossref

METTL3-STAT5B interaction facilitates the co-transcriptional m6A modification of mRNA to promote breast tumorigenesis

Poshan Yugal Bhattarai, Garam Kim, Sung-Chul Lim, Hong Seok Choi

Cancer Letters · 2024

DOI: 10.1016/j.canlet.2024.217215 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Letters, 2024. Verfasst von Poshan Yugal Bhattarai und 3 weiteren Autor:innen. Beteiligte Einrichtung: Research Institute of Pharmaceutical Sciences, College of Pharmacy, Chosun University, Gwangju, 61452, Republic of Korea. Hauptthemen laut MEDLINE: STAT5 Transcription Factor, Methyltransferases, Breast Neoplasms, RNA, Messenger. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 50 Literaturangaben. Gefördert von: National Research Foundation of Korea.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Enhanced expression of methyltransferase-like 3 (METTL3) promotes the m6A modification of specific mRNAs, contributing to breast tumorigenesis. While the mRNA substrates targeted by METTL3 are well characterized, the factors dictating the selection of these specific mRNA remain elusive. This study aimed to examine the regulatory role of the transcription factor STAT5B in METTL3-induced m6A modification. METTL3 specifically interacts with STAT5B in response to mitogenic stimulation by epidermal growth factor (EGF). Chromatin immunoprecipitation and CRISPR/Cas9 mutagenesis showed that STAT5B recruits METTL3 to gene promoters like CCND1, where METTL3 interacts with RPB1, dependent on CDK9-mediated RPB1 (Ser2) phosphorylation during transcription elongation. Inhibition and depletion of either STAT5B or CDK9 prevented the EGF-induced m6A modification of CCND1. The translation efficiency of CCND1 was increased following m6A modification, thereby increasing cell proliferation. STAT5B facilitated METTL3-induced tumor formation by increasing CCND1 expression in an orthotopic mouse model. In clinical context, a positive correlation was observed between p-STAT5B and METTL3 expression in high-grade breast tumors. This study elucidates a novel mechanism that underlies the specificity of m6A modification in breast cancer cells, thereby underscoring its potential therapeutic value.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

STAT5 Transcription FactorMethyltransferasesBreast NeoplasmsRNA, MessengerCyclin D1HumansFemaleAnimalsMiceGene Expression Regulation, NeoplasticCell ProliferationCyclin-Dependent Kinase 9CarcinogenesisCell Line, TumorAdenosinePhosphorylationPromoter Regions, GeneticEpidermal Growth Factor

Stichwörter der Autor:innen

Breast tumorigenesisCTD phosphorylationEpitranscriptomic regulationSTAT5B activationm(6)A modification

Substanzen

STAT5 Transcription FactorMethyltransferasesMETTL3 protein, humanRNA, MessengerCyclin D1CCND1 protein, humanSTAT5B protein, humanCyclin-Dependent Kinase 9CDK9 protein, humanAdenosine

Autor:innen und Institutionen

  • Research Institute of Pharmaceutical Sciences, College of Pharmacy, Chosun University, Gwangju, 61452, Republic of Korea.
  • Department of Pathology, School of Medicine, Chosun University, Gwangju, 61452, Republic of Korea.
  • Research Institute of Pharmaceutical Sciences, College of Pharmacy, Chosun University, Gwangju, 61452, Republic of Korea. Electronic address: chs@chosun.ac.kr.

Förderung

  • National Research Foundation of Korea

Zitieren

APA

Bhattarai, P. Y., Kim, G., Lim, S. C., & Choi, H. S. (2024). METTL3-STAT5B interaction facilitates the co-transcriptional m6A modification of mRNA to promote breast tumorigenesis. Cancer Letters. https://doi.org/10.1016/j.canlet.2024.217215

Vancouver

Bhattarai PY, Kim G, Lim SC, Choi HS. METTL3-STAT5B interaction facilitates the co-transcriptional m6A modification of mRNA to promote breast tumorigenesis. Cancer Letters. 2024. doi:10.1016/j.canlet.2024.217215

BibTeX
@article{Bhattarai2024,
  author = {Bhattarai, Poshan Yugal and Kim, Garam and Lim, Sung-Chul and Choi, Hong Seok},
  title = {METTL3-STAT5B interaction facilitates the co-transcriptional m6A modification of mRNA to promote breast tumorigenesis},
  journal = {Cancer Letters},
  year = {2024},
  doi = {10.1016/j.canlet.2024.217215}
}
Kostenlos starten →